NDC 58005-307 - ATROPINE SULFATE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 58005-307
- Package NDCs from labels
- 58005-307-04
- Manufacturer
- Sparhawk Laboratories, Inc.
- Effective date
- 2017-02-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ATROPINE SULFATE LA 15 MG | Sparhawk Laboratories, Inc. | 2017-02-01 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ATROPINE SULFATE | ACTIVE INGREDIENT | 03J5ZE7KA5 | ATROPINE SULFATE INJECTION, SOLUTION [SPARHAWK LABORATORIES, INC.] | 1 | |
| ATROPINE | ACTIVE MOIETY | 7C0697DR9I | ATROPINE SULFATE INJECTION, SOLUTION [SPARHAWK LABORATORIES, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Atropine Sulfate | ATROPINE SULFATE | A-S Medication Solutions | 739f384f-1a69-4953-93a0-aa6a76de0ecc | 2026-02-18 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| ATROPINE | ATROPINE SULFATE | A-S Medication Solutions | b4736dbc-b7c8-4b33-b7a8-a47c5654a127 | 2026-02-10 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine Sulfate | ATROPINE SULFATE | Bausch & Lomb Americas Inc. | e294ce2b-6bb5-4f84-8a6d-ce2402ed926d | 2026-02-07 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Hepaticol Drops 5008 | HEPATICOL DROPS | Professional Complementary Health Formulas | 79ee9e37-7853-4560-a87d-cdaefb603bbb | 2026-01-08 | Warnings | 03J5ZE7KA5 |
| Renal Drops 5024 | RENAL DROPS | Professional Complementary Health Formulas | e598ae46-3b14-4dce-b7e0-abf159d102db | 2026-01-08 | Warnings | 03J5ZE7KA5 |
| Adrenal Drops 5001 | ADRENAL DROPS | Professional Complementary Health Formulas | 9c120843-c43b-4a60-8eaa-d3a951e32ee4 | 2026-01-08 | Warnings | 03J5ZE7KA5 |
| Magnesium Combination 9232 | MAGNESIUM COMBINATION | Professional Complementary Health Formulas | 4d99b3ec-724f-4385-ae5e-83389bb0c8fe | 2026-01-08 | Warnings | 03J5ZE7KA5 |
| Atropine | ATROPINE SULFATE | Redpharm Drug | 46e98d0b-3a04-7feb-e063-6394a90ac75e | 2025-12-27 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine Sulfate | ATROPINE SULFATE | Redpharm Drug | 301ea0f4-a1dc-ad4f-e063-6294a90acc1c | 2025-12-23 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine Sulfate | ATROPINE SULFATE INJECTION | Medefil, Inc. | fbfdf718-befe-ad22-e053-6294a90a3715 | 2025-12-23 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Diphenoxylate Hydrochloride and Atropine Sulfate | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | ANI Pharmaceuticals, Inc. | 73dc5f91-d562-44c5-a556-66c96ed1dd82 | 2025-12-22 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine Sulfate | ATROPINE SULFATE | ProPharma Distribution | 38404931-980b-0019-e063-6394a90a933f | 2025-12-18 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine Sulfate | ATROPINE SULFATE | ProPharma Distribution | 3d5c747f-3bf7-2597-e063-6394a90a828c | 2025-12-18 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| GB-Tone | AMMI VIS, ATROPINUM SULPHURICUM, BOLDO, CARDUUS MAR, CHELIDONIUM MAJ, ECHINACEA, FEL TAURI, HEPAR SUIS, HYDRASTIS, LEPTANDRA, MAG PHOS, NAT PHOS, PODOPH PELT, TARAXACUM | Energetix Corporation | 1d857ae7-ad24-4f3b-8c33-f52851fa1ce6 | 2025-12-17 | Warnings | 03J5ZE7KA5 |
| Diphenoxylate Hydrochloride and Atropine Sulfate | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | Unichem Pharmaceuticals (USA), Inc. | 5117f26c-488f-4ba6-b115-22baf12557f3 | 2025-12-11 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Diphenoxylate hydrochloride and atropine sulfate | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | Chartwell RX, LLC | 240b537e-ff9b-45e3-9398-584372bd707a | 2025-12-10 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine | ATROPINE SULFATE | Amneal Pharmaceuticals NY LLC | f8718be5-8fa4-4c36-a4fd-fac7c3953f5a | 2025-12-04 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| atropine sulfate | ATROPINE SULFATE | Amneal Pharmaceuticals LLC | 80a31286-a741-4440-b200-290c08925d06 | 2025-12-01 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine Sulfate | ATROPINE SULFATE | NorthStar RxLLC | f750135c-e6bf-4aa7-a343-87b1204df94f | 2025-11-12 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Motofen | DIFENOXIN AND ATROPINE SULFATE | Sebela Pharmaceuticals Inc. | 4cd3f029-a5e3-5812-e054-00144ff8d46c | 2025-11-08 | Warnings, Adverse reactions | 03J5ZE7KA5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.